Terms: = Lung cancer AND FSTL3, FLRG, 10272, ENSG00000070404, O95633 AND Prognosis
3 results:
1. fstl3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Meng X; Zhao X; Zhou B; Song W; Liang Y; Liang M; Du M; Shi J; Gao Y
J Cancer Res Clin Oncol; 2024 Jan; 150(1):17. PubMed ID: 38240936
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma.
Zhang C; Huang Y; Fang C; Liang Y; Jiang D; Li J; Ma H; Jiang W; Feng Y
Cancer Biomark; 2023; 36(4):313-326. PubMed ID: 36938730
[TBL] [Abstract] [Full Text] [Related]
3. Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma.
Cai D; Xu Y; Ding R; Qiu K; Zhang R; Wang H; Huang L; Xie X; Yan H; Deng Y; Lin X; Shao J; Luo X; Duan C
Cytokine; 2020 Feb; 126():154868. PubMed ID: 31629110
[TBL] [Abstract] [Full Text] [Related]
